UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Methodological Quality Assessment of Meta-Analyses and Systematic Reviews of Probiotics in Inflammatory Bowel Disease and Pouchitis

PloS one, 2016-12, Vol.11 (12), p.e0168785-e0168785

2016

Volltextzugriff (PDF)

Efficacy and safety of vonoprazan–amoxicillin dual therapy for Helicobacter pylori first-line treatment: a single-center, randomized, controlled trial

Therapeutic advances in gastroenterology, 2023-01, Vol.16, p.17562848231190976-17562848231190976

2023

Volltextzugriff (PDF)

Probiotic Escherichia coli Nissle 1917 Expressing Elafin Protects Against Inflammation and Restores the Gut Microbiota

Frontiers in microbiology, 2022-05, Vol.13, p.819336-819336

2022

Volltextzugriff (PDF)

Imbalanced mucosal microcirculation in the remission stage of ulcerative colitis using probe-based confocal laser endomicroscopy

BMC gastroenterology, 2019-07, Vol.19 (1), p.114-114, Article 114

2019

Volltextzugriff (PDF)

Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling

Molecular cancer therapeutics, 2014-05, Vol.13 (5), p.1206-1216

2014

Volltextzugriff (PDF)

Helicobacter pylori induces caudal‐type homeobox protein 2 and cyclooxygenase 2 expression by modulating microRNAs in esophageal epithelial cells

Cancer science, 2018-02, Vol.109 (2), p.297-307

2018

Volltextzugriff (PDF)

Gain of Function of Ion Channel TRPV1 Exacerbates Experimental Colitis by Promoting Dendritic Cell Activation

Molecular therapy. Nucleic acids, 2020-12, Vol.22, p.924-936

2020

Volltextzugriff (PDF)

High Expression and Clinical Significance of Elafin in Colorectal Cancer

Gastroenterology research and practice, 2019-01, Vol.2019, p.4946824-7

2019

Volltextzugriff (PDF)

Eradication rate and safety of a “simplified rescue therapy”: 14‐day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of Helicobacter pylori infection previously failed in eradication: A real‐world, retrospective clinical study in China

Helicobacter (Cambridge, Mass.), 2022-10, Vol.27 (5), p.e12918-n/a

2022

Volltextzugriff (PDF)

Influence of Helicobacter pylori Infection and Eradication on Small Intestinal Bacterial Overgrowth and Abdominal Symptoms

Digestive diseases and sciences, 2024-04, Vol.69 (4), p.1293-1301

2024

Volltextzugriff (PDF)

Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease

Inflammatory bowel diseases, 2017-12, Vol.23 (12), p.2134-2141

2017

Volltextzugriff (PDF)

Mo1100 ESCHERICHIA COLI NISSLE 1917 EXPRESSING ELAFIN AMELIORATES THE INFLAMMATION IN COLONIC MUCOSA AND ENHANCES THE MUCOSAL EPITHELIAL BARRIER IN CHRONIC MICE COLITIS

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-788-S-788

2020

Volltextzugriff (PDF)

Menstrual blood‐derived mesenchymal stem cells attenuate inflammation and improve the mortality of acute liver failure combining with A2AR agonist in mice

Journal of gastroenterology and hepatology, 2021-09, Vol.36 (9), p.2619-2627

2021

Volltextzugriff (PDF)

Ulcerative colitis overall disease severity index predicts colectomy: a prospective cohort study

Revista española de enfermedades digestivas, 2024-02, Vol.116 (2), p.77-82

2024

Volltextzugriff (PDF)

Lactobacillus reuteri compared with placebo as an adjuvant in Helicobacter pylori eradication therapy: a meta-analysis of randomized controlled trials

Therapeutic advances in gastroenterology, 2024-01, Vol.17, p.17562848241258021

2024

Volltextzugriff (PDF)

Efficacy and safety of vonoprazan–amoxicillin dual therapy for first-line treatment: a single-center, randomized, controlled trial

Therapeutic advances in gastroenterology, 2023-08, Vol.16

2023

Volltextzugriff (PDF)

A real‐world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy or failed in previous amoxicillin‐containing therapies

Helicobacter (Cambridge, Mass.), 2023-04, Vol.28 (2), p.e12947-n/a

2023

Volltextzugriff (PDF)

Efficacy of Sucralfate-Combined Quadruple Therapy on Gastric Mucosal Injury Induced by Helicobacter pylori and Its Effect on Gastrointestinal Flora

BioMed research international, 2020, Vol.2020, p.4936318-14

2020

Volltextzugriff (PDF)

compared with placebo as an adjuvant in eradication therapy: a meta-analysis of randomized controlled trials

Therapeutic advances in gastroenterology, 2024-06, Vol.17

2024

Volltextzugriff (PDF)

Drinking water quality and inflammatory bowel disease: a prospective cohort study

Environmental science and pollution research international, 2023-06, Vol.30 (27), p.71171-71183

2023

Volltextzugriff (PDF)

Su2018 Macrophage Targeting Contributes to the Inhibitory Effects of Embelin on Colitis-Associated Cancer

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-576-S-576

2015

Volltextzugriff (PDF)

Helicobacter pylori induces caudal‐type homeobox protein 2 and cyclooxygenase 2 expression by modulating micro RNA s in esophageal epithelial cells

Cancer science, 2018-02, Vol.109 (2), p.297-307

2018

Volltextzugriff (PDF)

Macrophage targeting contributes to the inhibitory effects of embelin on colitis-associated cancer

Oncotarget, 2016-04, Vol.7 (15), p.19548-19558

2016

Volltextzugriff (PDF)

Mo1961 Embelin Suppresses Colitis-Associated Tumorigenesis by Inhibition IL-6/ STAT3 Signaling

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-705-S-705

2013

Volltextzugriff (PDF)

Tu1705 Let-7b Is Involved in the Inflammation and Immune Response Associated With Helicobacter pylori Infection by Targeting Toll-Like Receptor 4

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-826-S-826

2013

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(44)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(21)
Humans
(13)
Gastroenterology & Hepatology
(10)
Helicobacter Pylori
(7)
Inflammatory Bowel Disease
(7)
Physical Sciences
(7)
Chemistry
(6)
Male
(6)
Stereoisomerism
(6)
Chemistry, Organic
(5)
Female
(5)
Imines - Chemistry
(5)
Infections
(5)
Oncology
(5)
Organic Chemistry
(5)
Animals
(4)
Chemistry, Medicinal
(4)
Diastereoselective Syntheses
(4)
Diastereoselective Syntheses, Enantioselective Syntheses
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Methodological Quality Assessment of Meta-Analyses and Systematic Reviews of Probiotics in Inflammatory Bowel Disease and Pouchitis

Efficacy and safety of vonoprazan–amoxicillin dual therapy for Helicobacter pylori first-line treatment: a single-center, randomized, controlled trial

Probiotic Escherichia coli Nissle 1917 Expressing Elafin Protects Against Inflammation and Restores the Gut Microbiota

Imbalanced mucosal microcirculation in the remission stage of ulcerative colitis using probe-based confocal laser endomicroscopy

Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling

Helicobacter pylori induces caudal‐type homeobox protein 2 and cyclooxygenase 2 expression by modulating microRNAs in esophageal epithelial cells

Gain of Function of Ion Channel TRPV1 Exacerbates Experimental Colitis by Promoting Dendritic Cell Activation

High Expression and Clinical Significance of Elafin in Colorectal Cancer

Eradication rate and safety of a “simplified rescue therapy”: 14‐day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of Helicobacter pylori infection previously failed in eradication: A real‐world, retrospective clinical study in China

Influence of Helicobacter pylori Infection and Eradication on Small Intestinal Bacterial Overgrowth and Abdominal Symptoms

Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease

Mo1100 ESCHERICHIA COLI NISSLE 1917 EXPRESSING ELAFIN AMELIORATES THE INFLAMMATION IN COLONIC MUCOSA AND ENHANCES THE MUCOSAL EPITHELIAL BARRIER IN CHRONIC MICE COLITIS

Menstrual blood‐derived mesenchymal stem cells attenuate inflammation and improve the mortality of acute liver failure combining with A2AR agonist in mice

Ulcerative colitis overall disease severity index predicts colectomy: a prospective cohort study

Lactobacillus reuteri compared with placebo as an adjuvant in Helicobacter pylori eradication therapy: a meta-analysis of randomized controlled trials

Efficacy and safety of vonoprazan–amoxicillin dual therapy for first-line treatment: a single-center, randomized, controlled trial

A real‐world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy or failed in previous amoxicillin‐containing therapies

Efficacy of Sucralfate-Combined Quadruple Therapy on Gastric Mucosal Injury Induced by Helicobacter pylori and Its Effect on Gastrointestinal Flora

compared with placebo as an adjuvant in eradication therapy: a meta-analysis of randomized controlled trials

Drinking water quality and inflammatory bowel disease: a prospective cohort study

Su2018 Macrophage Targeting Contributes to the Inhibitory Effects of Embelin on Colitis-Associated Cancer

Helicobacter pylori induces caudal‐type homeobox protein 2 and cyclooxygenase 2 expression by modulating micro RNA s in esophageal epithelial cells

Macrophage targeting contributes to the inhibitory effects of embelin on colitis-associated cancer

Mo1961 Embelin Suppresses Colitis-Associated Tumorigenesis by Inhibition IL-6/ STAT3 Signaling

Tu1705 Let-7b Is Involved in the Inflammation and Immune Response Associated With Helicobacter pylori Infection by Targeting Toll-Like Receptor 4

Suchergebnisse filtern